Synbio Tech Inc. has received the Innovative Product Award for its products, heat-killed Lactobacillus kefiranofaciens M1 and SYNPETTM TRENAL from Taiwan Association for Lactic Acid Bacteria (TALAB). These two products stand out among the competitors due to their innovativeness, robust science and potential commercial success.
Lactobacillus kefiranofaciens M1 is the most superior strain selected from Mongolian kefir. Heat–inactivated bacteria, postbiotics are the hottest trend in the nutraceutical world today. Due to its unique health benefits and flexibility in terms of application, M1 has been widely appreciated by the customers in Taiwan as soon as it was launched, it also sparks interest among international partners and customers. Experimental results showed that M1 has a tendency to regulate Th1/Th2 immune balance and total IgE concentration in serum, and has the potential to reduce airway resistance, inflammation and improve allergic rhinitis and asthma.
SYNPETTM is a series of pet health functional products developed in collaboration with academic institutions and experts over the years and finally launched in July, 2022. It is a brand new probiotic solution for furry companions which has been validated by animal science and clinical trials. Clinical evidence demonstrated that SYNPETTM TRENAL help maintain kidney function, promote circulation in the body and metabolize harmful substances. It can be used as a daily kidney care supplement.
Synbio Tech not only makes substantial R&D investments every year, but also continuously improves its production capabilities and quality control for the technological and product innovation. The functional postbiotic M1 and the pet probiotic, SYNPETTM TRENAL winning the innovative awards acknowledge and recognize Synbio Tech's dedication towards research and development of probiotics and postbiotics which meets the customer's needs.